Mycophenolate Sodium Product Enquiry

Mycophenolate sodium (Myfortic® of Novartis) is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells. Mycophenolate sodium is indicated for the prevention of renal transplant rejection in adults. Mycophenolate sodium has also been used for the prevention of rejection in liver, heart, and/or lung transplants in children older than two years.An immunosuppressant that has drastically decreased the incidence of acute rejection in solid transplant recipients, Mycophenolate sodium is increasingly utilized as a steroid sparing treatment in immune-mediated disorders including immunoglobulin-A nephropathy, small vessel vasculitides, and psoriasis.

Chemical Name:

Mycophenolate Sodium


Description
sodium (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
37415-62-6
C17H19NaO6
sodiummycophenolate;MYCOPHENOLATE SODIUM;mycophenolicmonosodiumsalt;mycophenolicacidmonosodiumsalt;4-Hexenoic acid,6-(1,3-dihydro-4-hydroxy-6-Methoxy-7-Methyl-3-oxo-5-isobenzofuranyl)-4-Methyl-,sodiuM salt
Immunosuppressant
Note :
API/Substances covered by patents are not offered to the countries where valid Patent Law is in force. However, the final responsibility lies with the customer.
back-to-top